Heart valve disease

Handbook of Cardiac Anatomy, Physiology, and Devices: Second Edition

Volumn , Issue , 2005, Pages 527-549

  John, Ranjit ^a   Liao, Kenneth K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aortic regurgitation; Aortic sclerosis; Aortic stenosis; Biologic prosthetic valve; Mechanical prosthetic valve; Mitral regurgitation; Mitral stenosis; Tricuspid valve disease

Indexed keywords

EID: 84892340445     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-372-5_31     Document Type: Chapter

References (83)

1. Miller GW, ed. King of hearts. New York, NY: Times Books, 2000.
2. Bolman RM III, Black SM. Open cardiac repair under direct vision: F. John Lewis and the University of Minnesota. J Card Surg 2003;18:328-32, discussion 333.
3. Lewis RP, Herr RH, Starr A, Griswold HE. Aortic valve replacement with the Starr-Edwards ball-valve prosthesis. Indications and results. Am Heart J 1966;71:549-63.
4. Lillehei CW, Kaster RL, Coleman M, Bloch JH. Heart-valve replacement with Lillehei-Kaster pivoting disk prosthesis. NY State J Med 1974;74:1426-38.
5. Lillehei CW, Kaster RL, Bloch JH. New central flow pivoting disk aortic and mitral prosthesis. Clinical experience. NY State J Med 1972;72:1738.
6. Emery RW, Palmquist WE, Mettler E, Nicoloff DM. A new cardiac valve prosthesis: in vitro results. Trans Am Soc Artif Intern Organs 1978;24:550-56.
7. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006;114:e84-231.
8. El Oakley R, Kleine P, Bach DS. Choice of prosthetic heart valve in today's practice. Circulation 2008;117:253-56.
9. Oxenham H, Bloomfield P, Wheatley DJ, et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprosthesis. Heart 2003;89:715-21.
10. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000;36:1152-58.
11. Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg 2006;131:1267-73.
12. Bach DS, Metras J, Doty JR, Yun KL, Dumesnil JG, Kon ND. Freedom from structural valve deterioration among patients 60 years of age and younger undergoing Freestyle aortic valve replacement. J Heart Valve Diseases 2008;16:649-55.
13. Edmunds LHJr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-11.
14. Cheitlin MD, Douglas PS, Parmley WW. 26th Bethesda conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: Acquired valvular heart disease. J Am Coll Cardiol 1994;24:874-80.
15. Carabello BA. Aortic stenosis. N Engl J Med 2002;346:677-82.
16. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26.
17. Otto CM, Pearlman AS, Kraft CD, Miyake-Hull CY, Burwash IG, Gardner CJ. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography. J Am Coll Cardiol 1992;20:1160-67.
18. Krayenbuehl HP, Hess OM, Ritter M, Monrad ES, Hoppeler H. Left ventricular systolic function in aortic stenosis. Eur Heart J 1988;9:E19-23.
19. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: A mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982;307:1362-66.
20. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res 1981;48:76-87.
21. Koyanagi S, Eastham C, Marcus ML. Effects of chronic hypertension and left ventricular hypertrophy on the incidence of sudden cardiac death after coronary artery occlusion in conscious dogs. Circulation 1982;65:1192-97.
22. Ross J Jr., Braunwald E. Aortic stenosis. Circulation 1968;38:61-67.
23. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10.
24. Sprigings DC, Forfar JC. How should we manage symptomatic aortic stenosis in the patient who is 80 or older? Br Heart J 1995;74:481-84.
25. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988;9:E57-64.
26. Iivanainen AM, Lindroos M, Tilvis R, Heikkila J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996;78:97-101.
27. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol 1988;61:123-30.
28. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997;95:1686-744.
29. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;10:1291-95.
30. Rajamannan NM, Otto CM. Targeted therapy to prevent progression of calcific aortic stenosis. Circulation 2004;110:1180-82.
31. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: Postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation 1986;74:119-25.
32. Safian RD, Mandell VS, Thurer RE, et al. Postmortem and intraoperative balloon valvuloplasty of calcific aortic stenosis in elderly patients: mechanisms of successful dilation. J Am Coll Cardiol 19987;9:655-60.
33. Tsai TP, Denton TA, Chaux A, et al. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients > or=90 years of age. Am J Cardiol 1994;74:960-62.
34. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978;58:255-64.
35. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 1997;95:2395-400.
36. Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois- Rande JL, Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: Risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol 2001;37:2101-07.
37. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
38. Nitenberg A, Foult JM, Antony I, Blanchet F, Rahali M. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries. J Am Coll Cardiol 1988;11:478-86.
39. Fortuin NJ, Craige E. On the mechanism of the Austin Flint murmur. Circulation 1972;45:558-70.
40. Parker E, Craige E, Hood WP Jr. The Austin Flint murmur and the A wave of the apexcardiogram in aortic regurgitation. Circulation 1971;43:349-59.
41. Miller RR, Vismara LA, DeMaria AN, Salel AF, Mason DT. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: Improved cardiac performance and reduced regurgitant volume. Am J Cardiol 1976;38:564-67.
42. Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. N Engl J Med 1995;332:356-62.
43. Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Diagnostic imaging in the evaluation of suspected aortic dissection. Old standards and new directions. N Engl J Med 1993;328:35-43.
44. Yacoub MH, et al. Results of valve sparing operations for aortic regurgitation. Circulation 1983;68:311-21.
45. David TE. Aortic valve-sparing operations for aortic root aneurysm. Semin Thorac Cardiovasc Surg 2001;13:291-96.
46. Gorlin R, Gorlin S. Hydraulic formula for calculation of the area of stenotic mitral valve, other cardiac values and central circulatory shunts. Am Heart J 1951;41:1-29.
47. Rowe JC, Bland EF, Sprague HB, White PD. The course of mitral stenosis without surgery: Ten- and twenty-year perspectives. Ann Intern Med 1960;52:741-49.
48. Wood P. An appreciation of mitral stenosis. I. Clinical features. Br Med J 1954;4870:1051-63.
49. Edwards JE, Rusted IE, Scheifley CH. Studies of the mitral valve. II. Certain anatomic features of the mitral valve and associated structures in mitral stenosis. Circulation 1956;14:398-406.
50. Roberts WC, Perloff JK. Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function abnormally. Ann Intern Med 1972;77:939-75.
51. Olesen KH. The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 1962;24:349-57.
52. Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA 1993;270:1731-36.
53. Selzer A, Cohn KE. Natural history of mitral stenosis:Areview. Circulation 1972;45:878-90.
54. Hugenholtz PG, Ryan TJ, Stein SW, Abelmann WH. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability. Am J Cardiol 1962;10:773-84.
55. Braunwald E, Moscovitz HL, Amram SS, et al. The hemodynamics of the left side of the heart as studied by simultaneous left atrial, left ventricular, and aortic pressures; particular reference to mitral stenosis. Circulation 1955;12:69-81.
56. Holen J, Aaslid R, Landmark K, Simonsen S. Determination of pressure gradient in mitral stenosis with a non-invasive ultrasound Doppler technique. Acta Med Scand 1976;199:455-60.
57. Hatle L, Brubakk A, Tromsdal A, Angelsen B. Noninvasive assessment of pressure drop in mitral stenosis by Doppler ultrasound. Br Heart J 1978;40:131-40.
58. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure:Asimultaneous Doppler- catheterization study in 127 patients. J Am Coll Cardiol 1985;6:750-56.
59. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease. Br Heart J 1970;32:26-34.
60. Daley R, Mattingly TW, Holt CL, Bland EF, White PD. Systemic arterial embolism in rheumatic heart disease. Am Heart J 1951;42:566.
61. Abernathy WS, Willis PW III. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin 1973;5:131-75.
62. Adams GF, Merrett JD, Hutchinson WM, Pollock AM. Cerebral embolism and mitral stenosis: Survival with and without anticoagulants. J Neurol Neurosurg Psychiatry 1974;37:378-83.
63. Orrange SE, Kawanishi DT, Lopez BM, Curry SM, Rahimtoola SH. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation 1997; 95:382-89.
64. Higgs LM, Glancy DL, O'Brien KP, Epstein SE, Morrow AG. Mitral restenosis: an uncommon cause of recurrent symptoms following mitral commissurotomy. Am J Cardiol 1970;26:34-37.
65. Dahl JC, Winchell P, Borden CW. Mitral stenosis. A long term postoperative follow-up. Arch Intern Med 1967;119:92-97.
66. Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr. Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease. J Am Coll Cardiol 1990;16:1575-78.
67. ConnollyMW, Gelbfish JS, Jacobowitz IJ, et al. Surgical results for mitral regurgitation from coronary artery disease. J Thorac Cardiovasc Surg 1986;91:379-88.
68. Chatterjee K, Parmley WW, Swan HJ, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 1973;48:684-90.
69. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RW, Sonnenblick EH. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979;43:773-77.
70. Carabello BA. Mitral regurgitation: basic pathophysiologic principles. Part 1. Mod Concepts Cardiovasc Dis 1988;57:53-58.
71. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: Predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 1984;3:235-42.
72. Crawford MH, Souchek J, Oprian CA, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990;81:1173-81.
73. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191-97.
74. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830-37.
75. Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in highrisk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993;72:840-43.
76. Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance. J Am Coll Cardiol 1985;6:744-49.
77. Betriu A, Chaitman BR. Preoperative determinants of return to sinus rhythm after valve replacement. In: Cohn LH, Gallucci V, eds. Cardiac bioprosthesis. New York, NY: Yorke Medical Books, 1982:184-91.
78. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994;107:408-15.
79. Horskotte D, Schulte HD, Bircks W, Strauer BE. The effect of chordal preservation on late outcome after mitral valve replacement: A randomized study. J Heart Valve Dis 1993;2:150-58.
80. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction. Cardiol Clin 1995;13:73-83, 85.
81. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg 1994;58:668-75, discussion 675-76.
82. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022-28.
83. Silverman N. Tricuspid valve. In: Kaiser K, ed. Mastery of cardiac surgery. Philadelphia, PA: Lippincott-Raven, 1998:354-60.